Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
This review summarizes the mechanisms of action, side effects, effect on blood lipids, and reduction in cardiovascular morbidity and mortality of both established and emerging lipid-lowering drugs.
Review the optimal management of GI bleeding in patients receiving oral anticoagulants. When should reversal agents be used, and at what point should anticoagulation be resumed?
Patients with diabetes are at increased risk of cardiac illness and mortality. What is the impact of sodium-glucose cotransporter inhibitors on major adverse cardiovascular events in these patients?
Currently available oral medications for AF are inefficient and associated with dose-related adverse effects. Might direct pulmonary delivery via inhaler be a viable alternative?
Intravenous Diltiazem Versus Metoprolol in Acute Rate Control of Atrial Fibrillation/Flutter and Rapid Ventricular Response: A Meta-Analysis of Randomized and Observational Studies.
Mission Statement:
The American Journal of Cardiovascular Drugs promotes rational therapy and disease management within the discipline of cardiology by providing a regular program of independent review articles covering all aspects of the management of cardiovascular disorders, particularly the place in therapy of newer and established agents and procedures.
